Due Diligence: Ensuring Your Deal Doesn't Collapse Due to Regulatory, Clinical, Quality, or Data Integrity Issues

Thursday, July 18, 2019

Morgan Lewis partner Ann Begley hosts this webinar that will focus on the key regulatory, quality, and clinical issues, including data integrity failings, that must be reviewed when purchasing an FDA-regulated product or company, and how to adequately address those concerns in the due diligence phase.

The presentation will highlight issues that can create burdens in the integration phase or undermine a deal altogether, and how to ensure these issues are properly addressed in advance. The panel will address a “checklist” of items acquiring companies should consider as part of their due diligence, followed by a discussion of specific techniques these companies can use to determine whether due diligence issues exist.